0001735276-20-000105.txt : 20201130
0001735276-20-000105.hdr.sgml : 20201130
20201130160323
ACCESSION NUMBER: 0001735276-20-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201125
FILED AS OF DATE: 20201130
DATE AS OF CHANGE: 20201130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHARP PHILLIP A
CENTRAL INDEX KEY: 0001226295
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 201358180
MAIL ADDRESS:
STREET 1: BIOGEN INC LEGAL DEPARTMENT
STREET 2: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER NAME:
FORMER CONFORMED NAME: SHARP PHILIP A
DATE OF NAME CHANGE: 20030407
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-25
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001226295
SHARP PHILLIP A
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2020-11-25
4
M
0
30000
9.3
A
265633
D
Common Stock
2020-11-25
4
S
0
11523
124.3
D
254110
D
Common Stock
2020-11-25
4
S
0
15715
125.05
D
238395
D
Common Stock
2020-11-25
4
S
0
2117
126.16
D
236278
D
Common Stock
2020-11-25
4
S
0
645
127.44
D
235633
D
Common Stock
31266
I
by Trust
Stock Option (right to buy)
9.3
2020-11-25
4
M
0
30000
0.0
D
2012-06-09
2021-06-09
Common Stock
30000
0
D
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021.
Sale prices ranged from $123.65 to $124.64.
Sale prices ranged from $124.66 to $125.60.
Sale prices ranged from $125.72 to $126.60.
Sale prices ranged from $127.23 to $127.92.
Includes shares of ALNY common stock held in trusts for the benefit of the children of Dr. Sharp, of which the spouse of Dr. Sharp and children are the trustees.
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
2020-11-30